Login / Signup

Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil.

Stephen Z LevineYair GoldbergKazufumi YoshidaMyrto SamaraAndrea CiprianiTakeshi IwatsuboStefan LeuchtToshiaki A Furawaka
Published in: European psychiatry : the journal of the Association of European Psychiatrists (2021)
Our results inform clinicians regarding the extent of heterogeneity in cognitive functioning during treatment and contribute to trial design considerations.
Keyphrases
  • single cell
  • phase iii
  • study protocol
  • palliative care
  • electronic health record
  • cognitive decline
  • phase ii
  • combination therapy
  • machine learning
  • open label
  • mild cognitive impairment
  • artificial intelligence